Liling Jiang

Liling Jiang

Auto-generated profile, based on publicly available information

Liling Jiang

College of Furnishings and Industrial Design Nanjing Forestry University Nanjing China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2020 in Color Research & Application
Verified
Journal Article
Closed access
PDF file
LJLiling Jiang
Liling Jiang
Vien CheungVien Cheung
Vien Cheung
Stephen WestlandStephen Westland
Stephen Westland
PRPeter A. Rhodes
Peter A. Rhodes
LSLiming Shen
Liming Shen
LXLei Xu
Lei Xu

16 January 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
XSxianping Shi
xianping Shi
YZYueyuan Zheng
Yueyuan Zheng
LJLiling Jiang
Liling Jiang
BZBo Zhou
Bo Zhou
WYWei Yang
Wei Yang
HKH. Phillip Koeffler
H. Phillip Koeffler
Core regulatory circuitry (CRC)-dependent transcriptional network is critical for developmental tumors in children and young adults carrying few gene mutations. However, whether and how CRC contributes to transcription regulation in Ewing sarcoma is unknown. Here, we identify and functionally validate a CRC “trio” constituted by three transcription factors (TFs): KLF15, TCF4 and NKX2-2, in Ewing sarcoma cells. Epigenomic analyses demonstrate that EWS-FLI1, the primary fusion driver for this cancer, directly establishes super-enhancers of each of these three TFs to activate their transcription. In turn, KLF15, TCF4 and NKX2-2 co-bind to their own and each other’s super-enhancers and promoters, forming an inter-connected auto-regulatory loop. Functionally, CRC factors contribute significantly to cell proliferation of Ewing sarcoma bothin vitroandin vivo, and are all overexpressed in this cancer. Mechanistically, CRC factors exhibit prominent capacity of co-regulating the epigenome in cooperation with EWS-FLI1, occupying 77.2% of promoters and 55.6% of enhancers genome-wide. Downstream, CRC TFs coordinately regulate gene expression networks in Ewing sarcoma, directly controlling important signaling pathways for cancer, such as lipid metabolism pathway, PI3K/AKT and MAPK signaling pathways. Together, molecular characterization of the oncogenic CRC model advances our understanding of the biology of Ewing sarcoma. Moreover, this study identifies CRC-downstream genes and signaling pathways, which may contain potential targets for therapeutic intervention for this malignancy.